BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS

被引：309

作者：

CASATI, S

PASSERINI, P

CAMPISE, MR

GRAZIANI, G

CESANA, B

PERISIC, M

PONTICELLI, C

机构：

[1] OSPED MAGGIORE POLICLIN, IST SCI MED, MILAN, ITALY

[2] CILAG LTD, CLIN RES & DEV, SCHAFFHAUSEN, SWITZERLAND

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1987年 / 295卷 / 6605期

关键词：

D O I：

10.1136/bmj.295.6605.1017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1017 / 1020

页数：4

共 17 条

[1] KIDNEY AND ERYTHROPOIESIS
ADAMSON, JW
ESCHBACH, J
FINCH, CA
[J]. AMERICAN JOURNAL OF MEDICINE, 1968, 44 (05) : 725 - +
[2] [Anonymous], 1971, STAT PRINCIPLES EXPT
[3] HEMODYNAMICS OF UREMIC ANEMIA
COLEMAN, TG
[J]. CIRCULATION, 1972, 45 (02) : 510 - &
[4] DIXON WJ, 1981, BMDP STATISTICAL SOF
[5] Draper N.R, 1998, APPL REGRESSION ANAL, V326, DOI 10.1002/9781118625590
[6] DEVELOPMENT OF RADIOIMMUNOASSAYS FOR HUMAN ERYTHROPOIETIN USING RECOMBINANT ERYTHROPOIETIN AS TRACER AND IMMUNOGEN
EGRIE, JC
COTES, PM
LANE, J
DAS, REG
TAM, RC
[J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 99 (02) : 235 - 241
[7] ELWOOD PC, 1974, LANCET, V1, P891
[8] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL
ESCHBACH, JW
EGRIE, JC
DOWNING, MR
BROWNE, JK
ADAMSON, JW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) : 73 - 78
[9] AN EXTENSION OF BOXS RESULTS ON THE USE OF THE F DISTRIBUTION IN MULTIVARIATE-ANALYSIS
GEISSER, S
GREENHOUSE, SW
[J]. ANNALS OF MATHEMATICAL STATISTICS, 1958, 29 (03): : 885 - 891
[10] GORSKY JE, 1978, CLIN CHEM, V24, P1485